Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

Although the clinical and pathologic diagnosis of some melanomas is clear-cut, there are many histopathologic simulators of melanoma that pose problems. Over-diagnosis of melanoma can lead to inappropriate therapy and psychologic burdens, whereas under-diagnosis can lead to inadequate treatment of a deadly cancer. We used existing data on DNA copy number alterations in melanoma to assemble panels of fluorescence in situ hybridization (FISH) probes suitable for the analysis of paraffin-embedded tissue. Using FISH data from a training set of 301 tumors, we established a discriminatory algorithm and validated it on an independent set of 169 unequivocal nevi and melanomas as well as 27 cases with ambiguous pathology, for which we had long-term follow-up data. An algorithm-using signal counts from a combination of 4 probes targeting chromosome 6p25, 6 centromere, 6q23, and 11q13 provided the highest diagnostic discrimination. This algorithm correctly classified melanoma with 86.7% sensitivity and 95.4% specificity in the validation cohort. The test also correctly identified as melanoma all 6 of 6 cases with ambiguous pathology that later metastasized. There was a significant difference in the metastasis free survival between test-positive and negative cases with ambiguous pathology (P=0.003). Sufficient chromosomal alterations are present in melanoma that a limited panel of FISH probes can distinguish most melanomas from most nevi, providing useful diagnostic information in cases that cannot be classified reliably by current methods. As a diagnostic aid to traditional histologic evaluation, this assay can have significant clinical impact and improve classification of melanocytic neoplasms with conflicting morphologic criteria.

[1]  M. Martini,et al.  Cyclin D1 homogeneous staining regions by fluorescent in situ hybridization: a possible indicator of aggressive behavior in melanomas. , 2008, Archives of dermatology.

[2]  S. Lodha,et al.  Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting , 2008, Journal of cutaneous pathology.

[3]  D. Pinkel,et al.  Somatic activation of KIT in distinct subtypes of melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Thomas THE PLACE OF SENTINEL NODE BIOPSY IN MELANOMA AFTER THE MULTICENTER SELECTIVE LYMPHADENECTOMY TRIAL , 2006, ANZ journal of surgery.

[5]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[6]  Lisa M. Schwartz,et al.  Skin biopsy rates and incidence of melanoma: population based ecological study , 2005, BMJ : British Medical Journal.

[7]  Kerstin Heselmeyer-Haddad,et al.  Tumorigenesis and Neoplastic Progression Genomic Amplification of the Human Telomerase Gene ( TERC ) in Pap Smears Predicts the Development of Cervical Cancer , 2005 .

[8]  P. Leboit,et al.  Histological Diagnosis of Nevi and Melanoma , 2004, Steinkopff.

[9]  Chris Del Mar,et al.  Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners , 2004, The Medical journal of Australia.

[10]  R. Barnhill Pathology of Melanocytic Nevi and Malignant Melanoma , 1995, Springer New York.

[11]  M. D. P. Robert C. Burton B.S.,et al.  Current melanoma epidemic: A nonmetastasizing form of melanoma? , 2004, World Journal of Surgery.

[12]  Daniel Pinkel,et al.  Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.

[13]  Lukas Bubendorf,et al.  A fluorescence in situ hybridization‐based assay for improved detection of lung cancer cells in bronchial washing specimens , 2002, Cancer.

[14]  D. Elder,et al.  Pathology review of cases presenting to a multidisciplinary pigmented lesion clinic. , 2002, Archives of dermatology.

[15]  D. Troxel Diagnostic Errors in Surgical Pathology Uncovered by a Review of Malpractice Claims , 2001, International journal of surgical pathology.

[16]  R. Jenkins,et al.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. , 2000, The Journal of molecular diagnostics : JMD.

[17]  D. Pinkel,et al.  Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. , 1999, The Journal of investigative dermatology.

[18]  G. Burg,et al.  Experts and gold standards in dermatopathology: qualitative and quantitative analysis of the self-assessment slide seminar at the 17th colloquium of the International Society of Dermatopathology. , 1998, The American Journal of dermatopathology.

[19]  D. Pinkel,et al.  Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. , 1998, Cancer research.

[20]  L. Liotta,et al.  Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus. , 1998, Human pathology.

[21]  P. Gallagher,et al.  Aberrant diagnoses by individual surgical pathologists. , 1998, The American journal of surgical pathology.

[22]  M. Mihm,et al.  Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma. Association of Directors of Anatomic and Surgical Pathology. , 1998, Virchows Archiv : an international journal of pathology.

[23]  M. Mihm,et al.  Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma. Association of Directors of Anatomic and Surgical Pathology. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[24]  S. H. Kim,et al.  Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus. , 1997, Biochemical and biophysical research communications.

[25]  R. Jackson,et al.  Malignant melanoma: a review of 75 malpractice cases , 1997, International journal of dermatology.

[26]  W. Mooi,et al.  Quality assessment by expert opinion in melanoma pathology: experience of the Pathology Panel of the Dutch Melanoma Working Party , 1997, The Journal of pathology.

[27]  E. Farmer,et al.  Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. , 1996, Human pathology.

[28]  R. Corona,et al.  Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  C. Del Mar,et al.  Melanocytic lesions excised from the skin: what percentage are malignant? , 2010, Australian journal of public health.

[30]  B. Johansson,et al.  Isochromosomes in neoplasia , 1994, Genes, chromosomes & cancer.

[31]  D. Troxel,et al.  Problem Areas in Pathology Practice Uncovered by a Review of Malpractice Claims , 1994, The American journal of surgical pathology.

[32]  C. Lewis,et al.  A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. , 1994, Journal of the American Academy of Dermatology.

[33]  U. Francke,et al.  Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. , 1988, Journal of the National Cancer Institute.

[34]  S. Sait,et al.  Chromosome changes in metastatic human melanoma. , 1988, Cancer genetics and cytogenetics.

[35]  P. Nowell,et al.  Cytogenetics of human malignant melanoma and premalignant lesions. , 1984, Cancer genetics and cytogenetics.